Growing community of inventors

Seoul, South Korea

GwangPyo Ko

Average Co-Inventor Count = 4.10

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

GwangPyo KoWoon Ki Kim (2 patents)GwangPyo KoBoram Seo (2 patents)GwangPyo KoKyungchan Jeon (2 patents)GwangPyo KoJae-Ho Kim (1 patent)GwangPyo KoJwa-Min Nam (1 patent)GwangPyo KoJeong-Eun Park (1 patent)GwangPyo KoMouhong Lin (1 patent)GwangPyo KoCheonghoon Lee (1 patent)GwangPyo KoIn Sun Joo (1 patent)GwangPyo KoJeong Su Lee (1 patent)GwangPyo KoJiyeon Si (1 patent)GwangPyo KoIn Sun Joo (0 patent)GwangPyo KoJeong Su Lee (0 patent)GwangPyo KoGwangPyo Ko (4 patents)Woon Ki KimWoon Ki Kim (4 patents)Boram SeoBoram Seo (4 patents)Kyungchan JeonKyungchan Jeon (2 patents)Jae-Ho KimJae-Ho Kim (67 patents)Jwa-Min NamJwa-Min Nam (3 patents)Jeong-Eun ParkJeong-Eun Park (2 patents)Mouhong LinMouhong Lin (1 patent)Cheonghoon LeeCheonghoon Lee (1 patent)In Sun JooIn Sun Joo (1 patent)Jeong Su LeeJeong Su Lee (1 patent)Jiyeon SiJiyeon Si (1 patent)In Sun JooIn Sun Joo (0 patent)Jeong Su LeeJeong Su Lee (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Kobiolabs, Inc. (3 from 13 patents)

2. Seoul National University (2 from 1,562 patents)

3. Korea Food & Drug Administration (1 from 3 patents)


4 patents:

1. 11903980 - Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community

2. 11747333 - Detection method of target analyte using gold nanoprobe through overgrowth of copper crystal

3. 11510948 - Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community

4. 11365452 - Composition for diagnosing or predicting risk of metabolic syndrome or metabolic syndrome-related diseases using human oral microbiome

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/10/2025
Loading…